• 11671 Citations
  • 55 h-Index
1973 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Esteban Celis is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 19 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

  • SPORE in Prostate Cancer

    Young, C., Fatemi, M., Morris, J. C., Thibodeau, S. N., Vile, R., Vasmatzis, G., Jenkins, R. B., Bergstralh, E. J., Cheville, J., Klee, G., Tindall, D. J., Davis, B., Sargent, D., Layton, D., Vuk-Pavlovic, S., Celis, E., Thibodeau, S. N., Vile, R., Sargent, D., Vasmatzis, G., Young, C., Jenkins, R. B., Bergstralh, E. J., Cheville, J., Layton, D., Klee, G., Fatemi, M., Morris, J. C., Vuk-Pavlovic, S., Tindall, D. J. & Davis, B.

    National Institutes of Health

    8/31/018/31/13

    Project: Research project

  • Research Output

    Role of dendritic cell-mediated immune response in oral homeostasis: A new mechanism of osteonecrosis of the jaw

    Elsayed, R., Kurago, Z., Cutler, C. W., Arce, R. M., Gerber, J., Celis, E., Sultan, H., Elashiry, M., Meghil, M., Sun, C., Auersvald, C. M., Awad, M. E., Zeitoun, R., Elsayed, R., Eldin M. Elshikh, M., Isales, C. & Elsalanty, M. E., Feb 1 2020, In : FASEB Journal. 34, 2, p. 2595-2608 14 p.

    Research output: Contribution to journalArticle

    Open Access
  • PD-L1-specific helper T-cells exhibit effective antitumor responses: New strategy of cancer immunotherapy targeting PD-L1 in head and neck squamous cell carcinoma

    Hirata-Nozaki, Y., Ohkuri, T., Ohara, K., Kumai, T., Nagata, M., Harabuchi, S., Kosaka, A., Nagato, T., Ishibashi, K., Oikawa, K., Aoki, N., Ohara, M., Harabuchi, Y., Uno, Y., Takei, H., Celis, E. & Kobayashi, H., Jun 20 2019, In : Journal of Translational Medicine. 17, 1, 207.

    Research output: Contribution to journalArticle

    Open Access
  • 1 Scopus citations

    Primary tumor-induced immunity eradicates disseminated tumor cells in syngeneic mouse model

    Piranlioglu, R., Lee, E. M., Ouzounova, M., Bollag, R. J., Vinyard, A., Arbab, A. S., Marasco, D., Guzel, M., Cowell, J. K., Thangaraju, M., Chadli, A., Hassan, K. A., Wicha, M. S., Celis, E. & Korkaya, H., Dec 1 2019, In : Nature communications. 10, 1, 1430.

    Research output: Contribution to journalArticle

  • 4 Scopus citations

    The route of administration dictates the immunogenicity of peptide-based cancer vaccines in mice

    Sultan, H., Kumai, T., Nagato, T., Wu, J., Salazar, A. M. & Celis, E., Mar 13 2019, In : Cancer Immunology, Immunotherapy. 68, 3, p. 455-466 12 p.

    Research output: Contribution to journalArticle

  • 2 Scopus citations

    An osteopontin/CD44 immune checkpoint controls CD8+ T cell activation and tumor immune evasion

    Klement, J. D., Paschall, A. V., Redd, P. S., Ibrahim, M. L., Lu, C., Yang, D., Celis, E., Abrams, S. I., Ozato, K. & Liu, K., Dec 3 2018, In : Journal of Clinical Investigation. 128, 12, p. 5549-5560 12 p.

    Research output: Contribution to journalArticle

  • 6 Scopus citations